Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surveillan
Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surveillan
复制标题
无佐剂单价甲型 (H1N1)pdm09 流感疫苗预防逆转录聚合酶链反应证实的大流行性流感住院治疗的有效性：美国 10 个流感监测机构对儿童和成人进行的病例对照研究
DOI：
10.1093/cid/cit551
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Ryan
中科院分区：
文献类型：
--
作者：
Thompson,MarkG;Sokolow,LeslieZ;Almendares,Olivia;Openo,Kyle;Farley,MonicaM;Meek,James;Ray,Julie;Kirley,PamalaDaily;Reingold,Arthur;Aragon,Deborah;Hancock,Emily;Baumbach,Joan;Schaffner,William;Thomas,Ann;Lynfield,Ruth;Ryan
During 2009–2010, we examined 217 patients hospitalized with laboratory-confirmed pandemic influenza in 9 Influenza Hospitalization Surveillance Network sites and 413 age- and community-matched controls and found that a single dose of monovalent nonadjuvanted influenza A(H1N1)pdm09 vaccine was 50% (95% confidence interval, 13%–71%) effective in preventing hospitalization associated with A(H1N1)pdm09 virus infection.
